This Company is Exploding after FDA Approves its Tattoo Removal Device

Posted on

It was earlier this week that the Food & Drug Administration approved Soliton’s tattoo removal device and shares of the company have been skyrocketing.

The FDA approved the medical device maker’s Rapid Acoustic Pulse (RAP) device for tattoo removal. The device is an accessory for its black ink tattoo removal system for the arms, legs and torso.

The device had been awarded “best in show” by the American Society for Laser Medicine and Surgery.

“Receiving clearance from the FDA, while inline with our expectations, is nonetheless gratifying and validating, representing a bedrock for the commercialization plan of our RAP technology,” remarked Chris Capelli, president, CEO and co-founder of Soliton.

“This clearance to market allows us to begin the transition from R&D to expanded product development and commercialization within the tattoo removal segment.”

According to Soliton, the device safely converts 3,000 volts into finely controlled acoustic shockwaves at a rate of up to 100 pulses per second. The therapy does not cause heat or collateral tissue damage resulting in little potential for bruising, according to Soliton.

Disclaimer: We have no position in Soliton Inc. (NASDAQ: SOLY) and have not been compensated for this article.